The largest database of trusted experimental protocols

Discovery 16 ls

Manufactured by GE Healthcare
Sourced in United States

The Discovery-16 LS is a laboratory equipment product from GE Healthcare. It is designed for spectroscopic analysis and imaging applications. The core function of the Discovery-16 LS is to perform high-resolution, multi-modal imaging and spectroscopy.

Automatically generated - may contain errors

2 protocols using discovery 16 ls

1

FDG PET/CT Imaging Protocol for Diagnostic Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
All patients underwent 18F-FDG PET/CT examination at the nuclear medicine department. The FDG PET/CT studies were performed using a combined PET/CT machine (Discovery-16 LS; GE Healthcare, Waukesha, WI). All patients were imaged after fasting for a minimum of 6 hours except for water and medications. All patients were required to have <200 mg/dL blood glucose level prior to injection. 18F-FDG (5 MBq/kg) was injected intravenously. Whole body images from skull base to midthigh were obtained 60 ± 10 minutes after the injection (early images). Low-dose CT was performed for attenuation correction using the following parameters: 80 mA, 140 kV, and 5 mm slice thickness. PET images were obtained in 6-8 bed positions lasting 3 minutes each. The delayed imaging focusing on the liver was performed 135 ± 15 minutes after intravenous injection (delayed images) on the same scanner. PET images were reconstructed with and without correction for attenuation using an iterative algorithm then displayed for reading as sagittal, axial, and coronal views on Advantage Windows Workstation 4.5; GE Healthcare (GE Advantage, Buc, France).
+ Open protocol
+ Expand
2

Standardized 68Ga-DOTA-TATE PET/CT Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All 68Ga-DOTA-TATE PET/CT scans were conducted using a hybrid PET/CT scanner (Discovery- 16 LS; GE Healthcare, Waukesha, Wisconsin, USA) in the Nuclear Medicine Department. Iohexol (Omnipaque; GE Healthcare) was used as the oral contrast agent. 68Ga-DOTA-TATE (2 MBq/kg) was administered intravenously. Whole-body images from skull base to mid-thigh were acquired 60±10 minutes after the injection. A low-dose 16-slice multidetector CT scan (parameters: 80 mA, 140 kV, table speed 27 mm/rotation, and slice width of 5.0 mm) was used to screen the body from mid-thigh to the base of the skull. A standard whole-body PET scan was conducted in 3D mode with an acquisition time of 3 min per bed position (six to eight bed positions) scanning the exact area with the CT scan. PET images were reconstructed with and without correction for attenuation using an iterative algorithm. Next, a workstation (Advantage Windows Workstation 4.6; GE Advantage) was used for processing and interpretation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!